Cardinal Health (NYSE:CAH - Get Free Report) updated its FY 2025 earnings guidance on Friday. The company provided EPS guidance of 8.150-8.200 for the period, compared to the consensus EPS estimate of 8.130. The company issued revenue guidance of -.
Cardinal Health Stock Up 0.4%
NYSE:CAH opened at $165.51 on Friday. The firm has a market capitalization of $39.50 billion, a P/E ratio of 25.82, a P/E/G ratio of 1.85 and a beta of 0.66. Cardinal Health has a 12-month low of $93.17 and a 12-month high of $166.03. The stock's fifty day simple moving average is $148.90 and its 200-day simple moving average is $133.78.
Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The company reported $2.35 EPS for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. The business had revenue of $54.88 billion during the quarter, compared to analysts' expectations of $55.33 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 68.84%. The firm's quarterly revenue was up .0% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.08 EPS. As a group, equities research analysts expect that Cardinal Health will post 7.95 earnings per share for the current year.
Cardinal Health Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be given a dividend of $0.5107 per share. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date is Tuesday, July 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.23%. Cardinal Health's dividend payout ratio is currently 31.51%.
Analyst Ratings Changes
CAH has been the subject of a number of research reports. Mizuho increased their target price on Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a report on Monday, March 31st. Bank of America lifted their target price on Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research report on Tuesday, June 10th. Wall Street Zen raised Cardinal Health from a "buy" rating to a "strong-buy" rating in a research report on Monday, May 5th. Morgan Stanley set a $181.00 price target on shares of Cardinal Health and gave the stock an "overweight" rating in a research note on Friday, June 13th. Finally, Wells Fargo & Company raised shares of Cardinal Health from an "equal weight" rating to an "overweight" rating and boosted their price objective for the stock from $136.00 to $179.00 in a research report on Tuesday, June 3rd. Three investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $157.43.
Check Out Our Latest Stock Report on Cardinal Health
Hedge Funds Weigh In On Cardinal Health
A hedge fund recently raised its stake in Cardinal Health stock. Integrated Wealth Concepts LLC increased its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 6.9% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 4,363 shares of the company's stock after purchasing an additional 280 shares during the quarter. Integrated Wealth Concepts LLC's holdings in Cardinal Health were worth $601,000 as of its most recent SEC filing. 87.17% of the stock is owned by institutional investors and hedge funds.
About Cardinal Health
(
Get Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
